Little new in NICE draft guidance on patient group directions
Draft good practice guidance on patient group directions (PGDs) has been issued for consultation by the National Institute for Health and Care Excellence this week (3 April 2013).
The guidance largely reflects how PGDs currently operate. It clarifies the legislation in relation to PGDs, as well as the need for developing, authorising, using and updating them.
A NICE spokesman told PJ Online: "Although there is little in [it] that is different from how things operate now, the independent group who developed the draft guidance was aware of current variation in practice and this is captured within the draft."
The draft guidance is written in the context of the NHS in England, including independent organisations or contractors who are commissioned to provide NHS services, but will also be applicable, where appropriate, to some of the devolved administrations.
Stakeholders wishing to comment on the draft guidance, including providers and commissioners of health services in England and Wales, need to register with NICE as stakeholders by emailing firstname.lastname@example.org with a contact name, organisation and email address, using the subject heading "PGDs stakeholder registration 2013". The consultation period runs until 29 April 2013.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2013.11119602
Recommended from Pharmaceutical Press
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£75.00Buy now